ursolic acid and concanavalin a
ursolic acid has been researched along with concanavalin a in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Aggarwal, BB; Checker, R; Jayakumar, S; Kohli, V; Patwardhan, RS; Sainis, KB; Sandur, SK; Sethi, G; Sharma, D | 1 |
Jang, WS; Lee, M; Nam, KW; Song, HY; Zerin, T | 1 |
Other Studies
2 other study(ies) available for ursolic acid and concanavalin a
Article | Year |
---|---|
Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antioxidants; B-Lymphocytes; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Concanavalin A; Cytokines; Graft vs Host Disease; Lymphocyte Activation; Macrophages; Mice; Mitogen-Activated Protein Kinases; Mitogens; NF-kappa B; NFATC Transcription Factors; Oxidation-Reduction; Reactive Oxygen Species; Transcription Factor AP-1; Triterpenes; Up-Regulation; Ursolic Acid | 2012 |
Anti-inflammatory potential of ursolic acid in Mycobacterium tuberculosis-sensitized and concanavalin A-stimulated cells.
Topics: Alveolar Epithelial Cells; Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Concanavalin A; Cyclooxygenase 2; Drug Evaluation, Preclinical; Humans; Interleukin-6; Mice; Mycobacterium tuberculosis; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; RAW 264.7 Cells; Triterpenes; Ursolic Acid | 2016 |